Submission for Office of Management and Budget (OMB) Review; Social Services Block Grant Post-Expenditure Report, Pre-Expenditure Report, and Intended Use Plan (OMB #0970-0234), 10083-10084 [2024-02851]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–008, Managing Epilepsy Well
Network (MEW).
Date: May 9, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Catherine Barrett, Ph.D., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 718–
7664; Email: CBarrett@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP24–003, Cancer Prevention and
Control Research Network (CPCRN).
Date: May 1, 2024.
Time: 10 a.m.–6 p.m., EDT.
Place: Teleconference/Web
Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Natalie Brown, M.P.H., Scientific
Review Officer, National Center for
Chronic Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway,
Mailstop S106–3, Atlanta, Georgia
30341–3717. Telephone: (404) 639–
4601; Email: NBrown3@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02878 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2024–02882 Filed 2–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
VerDate Sep<11>2014
16:57 Feb 12, 2024
Jkt 262001
Submission for Office of Management
and Budget (OMB) Review; Social
Services Block Grant Post-Expenditure
Report, Pre-Expenditure Report, and
Intended Use Plan (OMB #0970–0234)
Office of Community Services,
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
SUMMARY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
10083
Community Services (OCS) is requesting
from OMB a three-year extension of the
Social Services Block Grant (SSBG)
Post-Expenditure Report, PreExpenditure Report, and Intended Use
Plan (OMB #0970–0234). OCS is
proposing to make minor editorial
modifications to some column titles in
the Pre- and Post-Expenditure Reports,
for clarification.
DATES: Comments are due within 30
days of publication. OMB must decide
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having full
consideration if OMB receives it within
30 days of this publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis,
states and territories are required to
submit the following reports: (1) An
Intended Use Plan that provides data
and narrative descriptions related to the
state’s SSBG program. The Intended Use
Plan includes details about the delivery
of SSBG services and the state agency
administering the SSBG Program. ACF
is proposing to expand the currently
approved information collection to
include the collection of states’
Intended Use Plans with a model
format. Recipients are required to
submit their Pre-Expenditure Report no
less than 30 days prior to the start of the
period covered by the report. (2) A PreExpenditure Report demonstrates the
state’s anticipated allocation of SSBG
funding among the 29 pre-defined SSBG
service categories. Historically, states
have submitted this report using the
Post-Expenditure Report Form, and the
associated burden is included in the
currently approved information
collection. Recipients are required to
submit their Intended Use Plan no less
than 30 days prior to the start of the
period covered by the report, together
with the Pre-Expenditure Report. (3) A
Post-Expenditure Report details the
state’s actual use of SSBG funding
among each of the 29 service categories.
E:\FR\FM\13FEN1.SGM
13FEN1
10084
Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices
Recipients are required to submit their
Post-Expenditure Report within 6
months of the end of the period covered
by the report.
The law governing the programs at
Title XX of the Social Security Act [42
U.S.C. 1397c] mandates states and
territories submit to the federal
administering office an Intended Use
Plan and Pre-Expenditure report. These
materials are to detail the planned use
of funds. At the end of the fiscal year,
the law also requires states to provide
the federal agency with a reconciliation
and efficacy. OCS is proposing to make
minor editorial modifications to some
column titles in the Pre- and PostExpenditure Reports, for clarification.
Respondents: Agencies that
administer the SSBG at the state or
territory level, including the 50 states;
the District of Columbia; the
Commonwealth of Puerto Rico;
Massachusetts Commission for the
Blind (M–CFB); and the territories of
American Samoa, Guam, the U.S. Virgin
Islands, and the Commonwealth of
Northern Mariana Islands.
of the actual use of grant funds in the
Post-Expenditure Report [42 U.S.C.
1397e].
The forms and model plans support
the states and territories in meeting the
statutory requirement and provide a
consistent set of tools for information
collection on the grants’ use for each
state, as well as grant wide. The state
and territory reports are congregated
and analyzed and, in turn, comprise the
SSBG Annual Report. The data informs
the program’s performance and
efficiency measures for program impact
ANNUAL BURDEN ESTIMATES
Average
burden hours
per response
Annual
burden
hours
Pre-Expenditure Report Form .........................................................................
Intended Use Plan ...........................................................................................
Post-Expenditure Reporting Form ...................................................................
57
57
57
1
1
1
2
40
110
114
2,280
6,270
Estimated Total Annual Burden Hours: ....................................................
........................
........................
........................
8,664
Authority: 42 U.S.C. 1397–1397e.
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024–02851 Filed 2–12–24; 8:45 am]
BILLING CODE 4184–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2001–D–0219]
Use of Data Monitoring Committees in
Clinical Trials; Draft Guidance for
Industry; Availability; Agency
Information Collection Activities;
Proposed Collection; Comment
Request
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA, Agency, or we) is
announcing the availability of a draft
guidance for industry entitled ‘‘Use of
Data Monitoring Committees in Clinical
Trials.’’ This guidance is intended to
assist sponsors of clinical trials in
determining when a data monitoring
committee (DMC) (also known as a data
and safety monitoring board (DSMB), a
data and safety monitoring committee
(DSMC), or an independent data
monitoring committee (IDMC)) would
be useful for trial monitoring and what
procedures and practices should be
considered to guide their operation.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Annual
number of
responses per
respondent
Total
number of
respondents
Instrument
VerDate Sep<11>2014
16:57 Feb 12, 2024
Jkt 262001
When finalized, this guidance will
supersede the final guidance for clinical
trial sponsors entitled ‘‘Establishment
and Operation of Clinical Trial Data
Monitoring Committees,’’ issued in
March 2006. This draft guidance is not
final nor is it in effect at this time.
DATES: Submit either electronic or
written comments on the draft guidance
by April 15, 2024 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
Submit electronic or written comments
on the proposed collection of
information in the draft guidance by
April 15, 2024.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2001–D–0219 for ‘‘Use of Data
Monitoring Committees in Clinical
Trials.’’ Received comments will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Pages 10083-10084]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02851]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for Office of Management and Budget (OMB) Review;
Social Services Block Grant Post-Expenditure Report, Pre-Expenditure
Report, and Intended Use Plan (OMB #0970-0234)
AGENCY: Office of Community Services, Administration for Children and
Families, Department of Health and Human Services.
ACTION: Request for public comments.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families' (ACF) Office of
Community Services (OCS) is requesting from OMB a three-year extension
of the Social Services Block Grant (SSBG) Post-Expenditure Report, Pre-
Expenditure Report, and Intended Use Plan (OMB #0970-0234). OCS is
proposing to make minor editorial modifications to some column titles
in the Pre- and Post-Expenditure Reports, for clarification.
DATES: Comments are due within 30 days of publication. OMB must decide
about the collection of information between 30 and 60 days after
publication of this document in the Federal Register. Therefore, a
comment is best assured of having full consideration if OMB receives it
within 30 days of this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. You can
also obtain copies of the proposed collection of information by
emailing [email protected]. Identify all emailed requests by
the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis, states and territories are
required to submit the following reports: (1) An Intended Use Plan that
provides data and narrative descriptions related to the state's SSBG
program. The Intended Use Plan includes details about the delivery of
SSBG services and the state agency administering the SSBG Program. ACF
is proposing to expand the currently approved information collection to
include the collection of states' Intended Use Plans with a model
format. Recipients are required to submit their Pre-Expenditure Report
no less than 30 days prior to the start of the period covered by the
report. (2) A Pre-Expenditure Report demonstrates the state's
anticipated allocation of SSBG funding among the 29 pre-defined SSBG
service categories. Historically, states have submitted this report
using the Post-Expenditure Report Form, and the associated burden is
included in the currently approved information collection. Recipients
are required to submit their Intended Use Plan no less than 30 days
prior to the start of the period covered by the report, together with
the Pre-Expenditure Report. (3) A Post-Expenditure Report details the
state's actual use of SSBG funding among each of the 29 service
categories.
[[Page 10084]]
Recipients are required to submit their Post-Expenditure Report within
6 months of the end of the period covered by the report.
The law governing the programs at Title XX of the Social Security
Act [42 U.S.C. 1397c] mandates states and territories submit to the
federal administering office an Intended Use Plan and Pre-Expenditure
report. These materials are to detail the planned use of funds. At the
end of the fiscal year, the law also requires states to provide the
federal agency with a reconciliation of the actual use of grant funds
in the Post-Expenditure Report [42 U.S.C. 1397e].
The forms and model plans support the states and territories in
meeting the statutory requirement and provide a consistent set of tools
for information collection on the grants' use for each state, as well
as grant wide. The state and territory reports are congregated and
analyzed and, in turn, comprise the SSBG Annual Report. The data
informs the program's performance and efficiency measures for program
impact and efficacy. OCS is proposing to make minor editorial
modifications to some column titles in the Pre- and Post-Expenditure
Reports, for clarification.
Respondents: Agencies that administer the SSBG at the state or
territory level, including the 50 states; the District of Columbia; the
Commonwealth of Puerto Rico; Massachusetts Commission for the Blind (M-
CFB); and the territories of American Samoa, Guam, the U.S. Virgin
Islands, and the Commonwealth of Northern Mariana Islands.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual number Average burden
Instrument Total number of responses hours per Annual burden
of respondents per respondent response hours
----------------------------------------------------------------------------------------------------------------
Pre-Expenditure Report Form..................... 57 1 2 114
Intended Use Plan............................... 57 1 40 2,280
Post-Expenditure Reporting Form................. 57 1 110 6,270
---------------------------------------------------------------
Estimated Total Annual Burden Hours:........ .............. .............. .............. 8,664
----------------------------------------------------------------------------------------------------------------
Authority: 42 U.S.C. 1397-1397e.
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024-02851 Filed 2-12-24; 8:45 am]
BILLING CODE 4184-24-P
